GlassScriptPhysician profile
Matthew Roger Olson
NPI 1730403494
$3,304.11
in general payments reported to CMS, 2019-2025
10 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2021: $69.36 · 2022: $734 · 2023: $669 · 2024: $326 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,543 · Travel and Lodging: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.83 |
| Travel and Lodging | $700.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,040.28 | 2019-2025 | Mako, Triathlon, T2 Alpha |
| Medtronic, INC. | $54.00 | 2022 | |
| Active Medical, LLC | $36.93 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $36.30 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $35.52 | 2019 | |
| Anika Therapeutics, INC. | $25.15 | 2021 | |
| Boston Scientific Corporation | $24.91 | 2024 | |
| Merck Sharp & Dohme LLC | $23.85 | 2023 | Bridion |
| Depuy Synthes Sales INC. | $14.05 | 2019 | |
| Biocomposites INC | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.